House Republicans amping criticism of Biden’s drug access policies

House Republican criticism of the Biden administration’s policies on access to drugs and policies that disincentivize biomedical innovation has been relatively muted, but that’s about to change.

The House Committee on Ways and Means Committee’s health subcommittee has scheduled a hearing May 10 to examine “policies that will have negative effects on medical innovation and reduce patient access to therapies.”...